Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals

Rachel Nugent, Melanie Y. Bertram, Stephen Jan, Louis Niessen, Franco Sassi, Dean T. Jamison, Eduardo González Pier, Robert Beaglehole

Research output: Contribution to journalArticle

Abstract

Reduction of the non-communicable disease (NCD) burden is a global development imperative. Sustainable Development Goal (SDG) 3 includes target 3·4 to reduce premature NCD mortality by a third by 2030. Progress on SDG target 3·4 will have a central role in determining the success of at least nine SDGs. A strengthened effort across multiple sectors with effective economic tools, such as price policies and insurance, is necessary. NCDs are heavily clustered in people with low socioeconomic status and are an important cause of medical impoverishment. They thereby exacerbate economic inequities within societies. As such, NCDs are a barrier to achieving SDG 1, SDG 2, SDG 4, SDG 5, and SDG 10. Productivity gains from preventing and managing NCDs will contribute to SDG 8. SDG 11 and SDG 12 offer clear opportunities to reduce the NCD burden and to create sustainable and healthy cities.

Original languageEnglish (US)
JournalThe Lancet
DOIs
StateAccepted/In press - Jan 1 2018

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nugent, R., Bertram, M. Y., Jan, S., Niessen, L., Sassi, F., Jamison, D. T., Pier, E. G., & Beaglehole, R. (Accepted/In press). Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals. The Lancet. https://doi.org/10.1016/S0140-6736(18)30667-6